JERSEY CITY, NJ--(Marketwire - November 27, 2007) - QUMAS, a leading provider of quality management and regulatory affairs solutions, today announced that PharmaMar, a biopharmaceutical company subsidiary of Spain-based Zeltia Group, has selected QUMAS DocCompliance™ as its regulatory content management system. With QUMAS DocCompliance, PharmaMar now has a single solution that enables it to electronically create, manage and securely store all content, reports and records related to bringing pharmaceutical drugs to market, a critical precursor for eCTD submission.